Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Tubulis
Entity

Tubulis

Tracked across 1 events · 8 articles · First seen Apr 07, 2026 · Last active Apr 10, 2026

Sentiment
90
Attention
4
Events
1
Relationships
1
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 90
Business
Gilead Sciences Acquires Tubulis for $5 Billion
Tubulis is being acquired by Gilead Sciences for up to $5 billion, recognizing its innovative ADC platform and promising clinical-stage candidates. This deal provides significant capital and resources for Tubulis' technology to reach a broader patient base.
Apr 07, 2026 · 8 articles
Key Actions (4)
100 Gilead Sciences acquired TubulisGilead Sciences Acquires...
90 Tubulis developed next-generation antibody-drug conjugatesGilead Sciences Acquires...
60 Tubulis partnered with Gilead SciencesGilead Sciences Acquires...
50 Tubulis partnered with Bristol Myers SquibbGilead Sciences Acquires...
Relationships (1)
JPMorgan Chase===JPMorgan Chase client ↔ Tubulis JPMorgan Chase===JPMorgan Chase served as the exclusive financial advisor to Tub
NEWSDESK
Track Tubulis live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.